# Single-cell transcriptomics revealed molecular vulnerability in a human midbrain-like organoid model of Parkinson’s disease

**Authors:** Jessica Jiaxin Xie, Matas Vitkauskas, Quyen Do, Tzuen Yih Saw, Alfred Xuyang Sun, Lin Yang, Tuck Wah Soong, Kah-Leong Lim, Eng-King Tan, Huck-Hui Ng, Jinyue Liu

PMC · DOI: 10.1016/j.isci.2026.114674 · iScience · 2026-01-10

## TL;DR

This study uses human midbrain-like organoids to uncover molecular vulnerabilities in Parkinson’s disease, revealing how specific cell types are affected.

## Contribution

The study identifies dopamine neuron subtypes and their vulnerability in a human midbrain-like organoid model of Parkinson’s disease.

## Key findings

- Four dopamine-producing neuron subtypes were identified with distinct molecular profiles linked to Parkinson’s vulnerability.
- PARK7 knockout in organoids caused mitochondrial and synaptic defects, mimicking Parkinson’s pathophysiology.
- Organoids showed α-synuclein aggregation and Lewy Body-like inclusions, resembling key features of Parkinson’s disease.

## Abstract

The human midbrain-like organoid (hMLO) is a key model system for investigating pathological features of Parkinson’s disease (PD), yet how its molecular landscape relates to cellular vulnerability in PD remains unclear. We performed in-depth single-cell characterization of our previously established hMLO model up to 150 days in vitro. Our hMLOs exhibited physiological cell types and broad topographical patterning, consistent with features of the human fetal midbrain. We further identified four distinct dopamine-producing neurons (DaN) subtypes whose molecular profiles span a key transcriptomic axis in the selective vulnerability of DaNs in PD. Knockout of PARK7, a highly penetrant PD-causing gene, in hMLOs induced cell type-dependent molecular perturbations in mitochondrial activity and synapse biology, and recapitulated PD pathophysiology, including α-synuclein aggregation, Lewy Body-like inclusions, and DaN degeneration with extended culture. This study highlights the utility of our hMLO model in manifesting pathological features and cell type-specific vulnerability, enabling mechanistic studies into PD pathophysiology.

•Comprehensive multi-omics evaluation of human midbrain-like organoids•Identified organoid analogs of human midbrain dopaminergic subtypes•Cell identities were differentially enriched for subsets of PD-linked genes•PARK7 loss induced broad mitochondrial defects but restricted synaptic dysfunction

Comprehensive multi-omics evaluation of human midbrain-like organoids

Identified organoid analogs of human midbrain dopaminergic subtypes

Cell identities were differentially enriched for subsets of PD-linked genes

PARK7 loss induced broad mitochondrial defects but restricted synaptic dysfunction

Disease; Molecular neuroscience; Integrative aspects of cell biology; Transcriptomics

## Linked entities

- **Genes:** PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315]
- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Genes:** ITPKB (inositol-trisphosphate 3-kinase B) [NCBI Gene 3707] {aka IP3-3KB, IP3K, IP3K-B, IP3KB, PIG37}, GRN (granulin precursor) [NCBI Gene 2896] {aka CLN11, FTD2, GEP, GP88, PCDGF, PEPI}, TMEM108 (transmembrane protein 108) [NCBI Gene 66000] {aka CT124, RTLN}, KLHL1 (kelch like family member 1) [NCBI Gene 57626] {aka MRP2}, EGLN3 (egl-9 family hypoxia inducible factor 3) [NCBI Gene 112399] {aka HIFP4H3, HIFPH3, PHD3}, GLRA2 (glycine receptor alpha 2) [NCBI Gene 2742] {aka GLR, MRXSP}, FGF8 (fibroblast growth factor 8) [NCBI Gene 2253] {aka AIGF, FGF-8, HBGF-8, HH6, KAL6}, MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4) [NCBI Gene 9448] {aka FLH21957, HEL-S-31, HGK, MEKKK4, NIK}, UCHL1 (ubiquitin C-terminal hydrolase L1) [NCBI Gene 7345] {aka HEL-117, HEL-S-53, NDGOA, PARK5, PGP 9.5, PGP9.5}, FSTL4 (follistatin like 4) [NCBI Gene 23105], Ttr (transthyretin) [NCBI Gene 22139] {aka prealbumin}, LRRK2 (leucine rich repeat kinase 2) [NCBI Gene 120892] {aka AURA17, DARDARIN, PARK8, RIPK7, ROCO2}, UNC5C (unc-5 netrin receptor C) [NCBI Gene 8633] {aka UNC5H3}, DNAJC13 (DnaJ heat shock protein family (Hsp40) member C13) [NCBI Gene 23317] {aka PARK21, RME8}, DCX (doublecortin) [NCBI Gene 1641] {aka DBCN, DC, LISX, SCLH, XLIS}, MANEA (mannosidase endo-alpha) [NCBI Gene 79694] {aka ENDO, hEndo}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, Foxg1 (forkhead box G1) [NCBI Gene 15228] {aka 2900064B05Rik, BF-1, Bf1, Hfh9, Hfhbf1}, GRIN2B (glutamate ionotropic receptor NMDA type subunit 2B) [NCBI Gene 2904] {aka DEE27, EIEE27, GluN2B, MRD6, NMDAR2B, NR2B}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, STBD1 (starch binding domain 1) [NCBI Gene 8987] {aka GENEX3414, GENX-3414}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, S100A10 (S100 calcium binding protein A10) [NCBI Gene 6281] {aka 42C, ANX2L, ANX2LG, CAL1L, CLP11, Ca[1]}, FAM47E (family with sequence similarity 47 member E) [NCBI Gene 100129583], PLA2G6 (phospholipase A2 group VI) [NCBI Gene 8398] {aka CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2, NBIA2A}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, NBL1 (NBL1, DAN family BMP antagonist) [NCBI Gene 4681] {aka D1S1733E, DAN, DAND1, NB, NO3}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, HES6 (hes family bHLH transcription factor 6) [NCBI Gene 55502] {aka C-HAIRY1, HES-6, bHLHb41, bHLHc23}, SPON1 (spondin 1) [NCBI Gene 10418] {aka VSGP/F-spondin, f-spondin}, LAMB2 (laminin subunit beta 2) [NCBI Gene 3913] {aka LAMS, NPHS5, PIERS}, CA4 (carbonic anhydrase 4) [NCBI Gene 762] {aka CAIV, Car4, RP17}, RFX4 (regulatory factor X4) [NCBI Gene 5992] {aka NYD-SP10}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}, SYNJ1 (synaptojanin 1) [NCBI Gene 8867] {aka DEE53, EIEE53, INPP5G, PARK20}, GRIA2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 2891] {aka GLUR2, GLURB, GluA2, GluR-K2, HBGR2, NEDLIB}, GJA1 (gap junction protein alpha 1) [NCBI Gene 2697] {aka AVSD3, CMDR, CX43, EKVP, EKVP3, GJAL}, RBFOX1 (RNA binding fox-1 homolog 1) [NCBI Gene 54715] {aka 2BP1, A2BP1, FOX-1, FOX1, HRNBP1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, EPHB1 (EPH receptor B1) [NCBI Gene 2047] {aka ELK, EPHT2, Hek6, NET}, STMN4 (stathmin 4) [NCBI Gene 81551] {aka RB3}, MAP2 (microtubule associated protein 2) [NCBI Gene 4133] {aka MAP-2, MAP2A, MAP2B, MAP2C}, DDC (dopa decarboxylase) [NCBI Gene 1644] {aka AADC}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}, FOXA1 (forkhead box A1) [NCBI Gene 3169] {aka HNF3A, TCF3A}, SLC1A3 (solute carrier family 1 member 3) [NCBI Gene 6507] {aka EA6, EAAT1, GLAST, GLAST1}, SLC17A6 (solute carrier family 17 member 6) [NCBI Gene 57084] {aka DNPI, VGLUT2}, MSX1 (msh homeobox 1) [NCBI Gene 4487] {aka ECTD3, HOX7, HYD1, STHAG1}, Trpm3 (transient receptor potential cation channel, subfamily M, member 3) [NCBI Gene 226025] {aka 6330504P12Rik, 9330180E14, B930001P07Rik, LTRPC3, MLSN2}, KCNH8 (potassium voltage-gated channel subfamily H member 8) [NCBI Gene 131096] {aka ELK, ELK1, Kv12.1, elk3, hElk-1}, PGK1 (phosphoglycerate kinase 1) [NCBI Gene 5230] {aka HEL-S-68p, MIG10, PGKA}, EN1 (engrailed homeobox 1) [NCBI Gene 2019] {aka ENDOVESLB}, GBA1LP (glucosylceramidase beta 1 like, pseudogene) [NCBI Gene 2630] {aka GBAP, GBAP1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, CTSB (cathepsin B) [NCBI Gene 1508] {aka APPS, CPSB, KWE, RECEUP}, OTX2 (orthodenticle homeobox 2) [NCBI Gene 5015] {aka CPHD6, MCOPS5}, DNAJC6 (DnaJ heat shock protein family (Hsp40) member C6) [NCBI Gene 9829] {aka DJC6, PARK19}, RIMS1 (regulating synaptic membrane exocytosis 1) [NCBI Gene 22999] {aka CORD7, RAB3IP2, RIM, RIM1}, CCL14 (C-C motif chemokine ligand 14) [NCBI Gene 6358] {aka CC-1, CC-3, CKB1, HCC-1, HCC-1(1-74), HCC-1/HCC-3}, STMN2 (stathmin 2) [NCBI Gene 11075] {aka SCG10, SCGN10}
- **Diseases:** hypoxic (MESH:D002534), DaN degeneration (MESH:D009410), necrotic (MESH:D009336), mitochondrial dysregulation (MESH:D021081), synaptic dysfunction (MESH:C536122), NULL (MESH:C564833), hypoxia (MESH:D000860), DaNs (MESH:C567730), neurodegeneration (MESH:D019636), mitochondrial defects (MESH:C565376), Familial PD (MESH:D010300), neurotoxic (MESH:D020258), hMLO (MESH:D020295), LBLI (MESH:D020961), MERFISH (MESH:D015456), lysosomal dysfunction (MESH:D016464)
- **Chemicals:** CO2 (MESH:D002245), MitoSOX Red (MESH:C000597839), citrate (MESH:D019343), SB431542 (MESH:C459179), Thioflavin S (MESH:C009462), TBS (MESH:D013725), taurocholic acid (MESH:D013656), vitamin A (MESH:D014801), sucrose (MESH:D013395), paraformaldehyde (MESH:C003043), CHIR99021 (MESH:C473711), L-cysteine (MESH:D003545), ascorbic acid (MESH:D001205), SDS (MESH:D012967), acetic acid (MESH:D019342), glutamate (MESH:D018698), heparin (MESH:D006493), GABA (MESH:D005680), Tween 20 (MESH:D011136), PBS (MESH:D007854), dopamine (MESH:D004298), glycine (MESH:D005998), db-cAMP (MESH:D003994), mitoSOX (MESH:C521281), serotonin (MESH:D012701), EtOH (MESH:D000431), GlutaMAX (MESH:C054122), 4',6-diamidino-2-phenylindole (MESH:C007293), OCT (MESH:C051883), DMEM (-), thiazovivin (MESH:C545214), phosphate (MESH:D010710), purmorphamine (MESH:C470893), EDTA (MESH:D004492), N2 (MESH:D009584), Chromium (MESH:D002857), DA (MESH:C025953), F12 (MESH:C007782), amino acid (MESH:D000596), Triton X-100 (MESH:D017830)
- **Species:** Mycoplasma (genus) [taxon 2093], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** 3D, 4 C, N370S, S3H, T2A, G2019S, V3, S4C
- **Cell lines:** H9 — Homo sapiens (Human), Sezary syndrome, Cancer cell line (CVCL_1240), MERFISH — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_YK69), hESC — Homo sapiens (Human), Embryonic stem cell (CVCL_9771), DaN1 — Homo sapiens (Human), Pancreatic adenocarcinoma, Cancer cell line (CVCL_0243), MLO — Mus musculus (Mouse), Transformed cell line (CVCL_0P24), hMLO — Homo sapiens (Human), Human papillomavirus-related cervical squamous cell carcinoma, Cancer cell line (CVCL_WU75), hESCs — Homo sapiens (Human), Embryonic stem cell (CVCL_UI95)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12918236/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12918236/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12918236/full.md

---
Source: https://tomesphere.com/paper/PMC12918236